Dolby Laboratories Stock Plummets to New 52-Week Low at $58.13

Dolby Laboratories, Inc. has reached a new 52-week low, trading at USD 58.13 as of March 25, 2026. This marks a significant decline for the small-cap software company, which has seen its stock price decrease by 25.88% over the past year, contrasting sharply with the S&P 500's performance of 13.68% during the same period. The company, with a market capitalization of USD 5,846 million, has been grappling with stagnant growth, as evidenced by its annual net sales growth rate of just 2.52% and an operating profit growth rate of 3.12% over the last five years. Recent quarterly results have also shown a decline, with pre-tax profit falling by 33.05% to USD 54.97 million and net profit down by 31.39% to USD 45.61 million. Despite a relatively low debt-to-equity ratio of -0.28 and a return on equity of 9.98%, Dolby's stock is trading at a premium compared to its peers. The company’s price-to-book ratio stands at 2.25, indicating a valuation that may not align with its recent performance metrics.